Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
35 studies found for:    " May 23, 2012":" June 22, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" May 23, 2012":" June 22, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed HIV Disclosure and Medication Adherence, a Pilot Study
Condition: HIV Infection
Intervention:
2 Active, not recruiting Clinical Trial to Reduce Drinking in Women With HIV
Condition: HIV Infection
Interventions: Drug: Naltrexone;   Drug: Placebo
3 Completed Phase 3 Safety and Effectiveness Trial of Dapivirine Vaginal Ring for Prevention of HIV-1 in Women
Condition: HIV Infections
Interventions: Drug: Dapivirine;   Drug: Placebo
4 Completed Evaluation of Behavioral Intervention for HIV Positive Prisoners in NC and TX
Condition: HIV Infection
Interventions: Behavioral: Text reminders, counseling, and link coordination;   Behavioral: Standard of care - control arm
5 Completed Adding Maraviroc to the HAART Regimen of Well Controlled HIV-infected Patients
Condition: HIV Infection
Intervention: Drug: Maraviroc
6 Completed A Study of Ritonavir-Boosted Invirase (Saquinavir) in Treatment-Naïve HIV-1 Infected Patients
Condition: HIV Infections
Interventions: Drug: Nucleoside Reverse Transcriptase Inhibitor (NRTIs);   Drug: ritonavir;   Drug: saquinavir [Invirase]
7 Completed
Has Results
A Pharmacokinetic Study to Evaluate the Effect of Antacids on Raltegravir (MK-0518) in HIV-Infected Participants (MK-0518-247)
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: TUMS® Ultra Strength;   Drug: MINTOX® Maximum Strength
8 Recruiting Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 28 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
Condition: HIV Infections
Interventions: Drug: Lamivudine/zidovudine;   Drug: Efavirenz;   Drug: Raltegravir
9 Completed Observational Study of HIV Infection in Participants of Seroconvert During Dapivirine Vaginal Ring Trials
Condition: HIV Infections
Intervention: Drug: No Investigational Product
10 Completed Linking Infectious and Narcology Care in Russia
Conditions: HIV Infection;   Drug Use
Intervention: Behavioral: LINC Case Management
11 Completed Darunavir Levels, Virological Efficacy, Proviral ADN and Resistances in Patients on Darunavir/Ritonavir Monotherapy
Condition: HIV-infection
Intervention: Drug: Darunavir/ritonavir
12 Completed Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women
Conditions: HIV Infection;   Pregnancy
Intervention:
13 Completed
Has Results
Metabolic Abnormalities in HIV-infected Persons
Conditions: Lipodystrophy;   HIV Infection
Interventions: Drug: Metformin;   Drug: Pioglitazone
14 Completed Evaluation of Barriers to Postpartum Care in HIV Infected Women
Conditions: HIV Infection;   Pregnancy
Intervention: Other: questionaires and structured interviews
15 Completed An Observational Study to Evaluate Tolerability of PREZISTA or INTELENCE in HIV-1 Infected Patients
Condition: Human Immunodeficiency Virus (HIV)
Interventions: Drug: darunavir (PREZISTA);   Drug: etravirine (INTELENCE);   Drug: ritonavir;   Drug: Other antiretroviral medications
16 Completed
Has Results
Etravirine Pharmacokinetics and HIV Viral Load in Breast Milk and Plasma
Condition: HIV
Intervention: Drug: Etravirine pharmacokinetics in breast milk and plasma
17 Active, not recruiting Alcohol's Impact on Inflammatory Markers in HIV Disease - Russia ARCH Cohort
Conditions: HIV Infection;   Alcohol Use
Intervention:
18 Completed Outcomes for Antiretroviral Therapy Patients Receiving Palliative Care
Condition: HIV
Interventions: Other: Palliative care;   Other: Standard care
19 Completed
Has Results
HIV Posterior Cheek Enlargement
Condition: HIV Posterior Cheek Enlargement
Intervention: Biological: Botulinum toxin A
20 Completed Immunotherapy With Vacc-C5 With Adjuvant GM-CSF or Alhydrogel in HIV-1-infected Subjects on ART
Condition: HIV-1 Infection
Interventions: Drug: Vacc-C5/GM-CSF;   Drug: Vacc-C5/Alhydrogel

   Previous Page Studies Shown (1-20) Next Page (21-35) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.